|Status : Upcoming||Report Code : VRHC1127||Industry : Healthcare||Available Format :|
Industry Insights by Product (Biopsy Needles, Biopsy Tables, Guidance Systems, Localization Wires and Others), by Type (Needle Breast Biopsy (Fine-Needle Aspiration Biopsy (FNAB), Vacuum-Assisted Biopsy (VAB), and Core-Needle Biopsy (CNB)), and Open Surgical Breast Biopsy (Excisional and Incisional)), by Guidance Techniques (Mammography-Guided Stereotactic, MRI-Guided, Ultrasound-Guided and Other Guidance Techniques), and End User (Diagnostic Centers, Hospitals, and Others)
A breast biopsy is a procedure which involves surgical removal of tissue or fluid to determine the presence of a disease. It requires the guiding system to locate an abnormality in the breast region. The global breast biopsy devices market is growing at a significant rate, due to the mounting occurrence of breast cancer among women and escalating number of breast cancer screening programs. Different types such as needle breast biopsy and open surgical breast biopsy contributed to the breast biopsy devices market size. The market has witnessed a high demand for needle breast biopsy due to the need for the scar-less and painless procedure.
Insight by Product
On the basis of product, the market is subdivided into biopsy needles, guidance systems, localization wires, biopsy tables, and others. The biopsy needles segment accounted the largest share in the market. Moreover, the guidance systems segment is expected to grow at the fastest rate in the market.
Insight by Type
On the basis of the type, the market is subdivided into needle breast biopsy, and open surgical breast biopsy. Of all the types, the needle breast biopsy is expected to grow at a faster rate in the breast biopsy devices market due to the need for the scar-less and painless procedure.
The needle breast biopsy is further subdivided into fine-needle aspiration biopsy (FNAB), a vacuum-assisted biopsy (VAB), and core-needle biopsy (CNB). The vacuum-assisted biopsy (VAB) is expected to grow at the fastest rate in the market due to escalating demand for the less invasive breast biopsy procedure. The fine-needle aspiration biopsy segment accounted the largest share in the market, due to mounting need for minimally invasive procedures.
Moreover, the open surgical breast biopsy is further subdivided into excisional and incisional.
Insight by Guidance Techniques
On the basis of application, the market is subdivided into mammography-guided stereotactic, MRI-guided, ultrasound-guided and other guidance techniques. Among all guidance techniques, the ultrasound-guided segment is expected to grow at the fastest rate in the breast biopsy devices market due to mounting demand for non-radiation and minimally invasive breast biopsy. Moreover, the mammography-guided stereotactic segment accounted the largest share in the market.
Insight by End User
On the basis of the end user, the market is subdivided into the diagnostic center, hospitals, and others. Among all end users, the diagnostic center segment accounted the largest share in the breast biopsy devices market.
Development of liquid biopsy is the trend in the breast biopsy devices market.
The mounting occurrence of breast cancer among women, technological advancement in breast imaging equipment, intensifying alertness regarding breast cancer, and escalating demand for minimally invasive surgeries are the primary growth drivers for breast biopsy devices market.
Novel reimbursement rules for breast biopsy procedures in the U.S., aging women population, and a mounting number of breast cancer screening programs are also facilitating the growth of the breast biopsy devices market.
Indeterminate regulatory guidelines, elevated procedure price, and risk of infection due to breast biopsy procedure are the major challenges for the growth of breast biopsy devices market.
Globally, the manufacturing companies trying to enter the breast biopsy devices market are required to maintain stringent regulatory standards. Moreover, the high level of capital requirement also poses a major barrier to the entry of new players. This offers an edge to the established players in the industry competition.
Geographically, North America is the largest breast biopsy devices market as in the region the occurrence of breast cancer is increasing and escalating alertness of recently developed technologies. In addition, elevated healthcare expenditure, and expanding geriatric population are also up surging growth of the North American breast biopsy devices market.
Asia-Pacific is observed to witness the fastest growth in the market, due to the mounting occurrence of breast cancer. In addition, expanding geriatric population, large population base, and escalating alertness regarding the breast cancer and screening programs are also creating a positive impact on the breast biopsy devices market growth in the region.
Key players in the breast biopsy devices market are catering to the demand of these devices by investing in technologically advanced products in their product portfolio across the globe. In March 2018, Planmed Oy received approval for Planmed Clarity 2D digital mammography system and the Planmed Clarity 3D digital mammography tomosynthesis system from Health Canada. Becton, Dickinson and Company, Cook Medical Incorporated, Hologic Inc., Medtronic PLC., Sterylab S.R.L., Danaher Corporation, Siemens AG, Intact Medical Corporation, and Planmed Oy are the key players offering breast biopsy devices.